# Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

> **NCT07144228** · — · RECRUITING · sponsor: **Duke University** · enrollment: 300 (estimated)

## Conditions studied

- Prostate Cancer (Diagnosis)

## Interventions

- **DEVICE:** HeLP TM

## Key facts

- **NCT ID:** NCT07144228
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-11
- **Primary completion:** 2026-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144228, "Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07144228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*